Percheron Therapeutics Ltd (ASX:PER – Get Free Report) insider James Garner acquired 39,500,000 shares of the business’s stock in a transaction dated Wednesday, February 26th. The stock was acquired at an average price of A$0.01 ($0.01) per share, with a total value of A$474,000.00 ($296,250.00).
James Garner also recently made the following trade(s):
- On Tuesday, December 24th, James Garner purchased 1,500,000 shares of Percheron Therapeutics stock. The stock was bought at an average cost of A$0.01 ($0.00) per share, for a total transaction of A$10,500.00 ($6,562.50).
Percheron Therapeutics Stock Performance
About Percheron Therapeutics
Recommended Stories
- Five stocks we like better than Percheron Therapeutics
- Golden Cross Stocks: Pattern, Examples and Charts
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- What is a Secondary Public Offering? What Investors Need to Know
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Percheron Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Percheron Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
